Jasveen Sangha, known as the Ketamine Queen, was sentenced to 15 years in prison for supplying the ketamine that contributed to the death of actor Matthew Perry. Prosecutors stated her customers, including Perry, were aware of her role in distributing the drug. Perry, 54, died on Oct. 28, 2023, from an acute ketamine overdose after being found unresponsive in a Los Angeles hot tub. The medical examiner’s report confirmed the substance caused his death, sparking renewed scrutiny of celebrity drug-related fatalities.

Sangha’s operation, which catered to high-profile clients, drew attention for its scale and secrecy. While prosecutors did not disclose specific buyers, the case highlights the dangers of unregulated pharmaceutical distribution in affluent circles. Her defense team argued she acted under medical guidance, but the court rejected this, emphasizing her knowing involvement in illegal sales.

The sentencing follows a two-year trial marked by explosive testimony and public interest. Legal experts note the case sets a precedent for holding suppliers accountable in celebrity overdose cases. Perry’s death, which occurred nearly a decade after his initial struggles with addiction, underscored the persistent risks of substance abuse in the entertainment industry.

Why this matters: The ruling signals stricter enforcement against drug traffickers, particularly those linked to high-profile fatalities. It also raises questions about prevention measures for celebrities and the role of law enforcement in monitoring illicit drug networks.